HTL0016878

DRUG2 trials

Sponsors

Nxera Pharma UK Limited

Conditions

HealthyHealthy Subjects

Phase 1

A Two Part Study to Assess Safety, PK, PD, and Food Effect of Oral HTL0016878

CompletedNCT03244228

Nxera Pharma UK LimitedHealthy

Start: 2017-08-25End: 2019-09-23Updated: 2019-11-29

Measurement of HTL0016878 in Cerebrospinal Fluid

CompletedNCT04849286

Nxera Pharma UK LimitedHealthy Subjects

Start: 2018-09-26End: 2018-12-07Updated: 2021-04-19